Identification of RELN variant p.(Ser2486Gly) in an Iranian family with ankylosing spondylitis; the first association of RELN and AS.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
06 2020
Historique:
received: 13 04 2019
accepted: 03 12 2019
revised: 11 11 2019
pubmed: 1 2 2020
medline: 28 5 2021
entrez: 1 2 2020
Statut: ppublish

Résumé

Ankylosing spondylitis (AS) is a common complex inflammatory disease; however, up to now distinct genes with monogenic pattern have not been reported for this disease. In the present study, we report a large Iranian family with several affected members with AS. DNAs of the three affected and two healthy cases were chosen for performing whole-exome sequencing (WES). After several filtering steps, candidate variants in the following genes were detected: RELN, DNMT1, TAF4β, MUC16, DLG2, and FAM208. However, segregation analysis confirmed the association of only one variant, c.7456A>G; p.(Ser2486Gly) in the RELN gene with AS in this family. In addition, in silico predictions supported the probable pathogenicity of this variant. In this study, for the first time, we report a novel variant in the RELN gene, c.7456A>G; p.(Ser2486Gly), which completely co-segregates with AS. This association suggests potential insights into the pathophysiological bases of AS and it could broaden horizons toward new therapeutic strategies.

Identifiants

pubmed: 32001840
doi: 10.1038/s41431-020-0573-4
pii: 10.1038/s41431-020-0573-4
pmc: PMC7253431
doi:

Substances chimiques

Cell Adhesion Molecules, Neuronal 0
Extracellular Matrix Proteins 0
Nerve Tissue Proteins 0
Reelin Protein 0
RELN protein, human EC 3.4.21.-
Serine Endopeptidases EC 3.4.21.-

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

754-762

Références

El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med. 2011;22:554–60.
pubmed: 22075279 doi: 10.1016/j.ejim.2011.06.006
Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:65–73.
pubmed: 23999006 doi: 10.1136/annrheumdis-2013-203582
Schett G. Bone formation versus bone resorption in ankylosing spondylitis: molecular mechanisms of spondyloarthropathies. Springer; New York, NY. 2009;114–21.
Robinson PC, Brown MA. Genetics of ankylosing spondylitis. Mol Immunol. 2014;57:2–11.
pubmed: 23916070 doi: 10.1016/j.molimm.2013.06.013
Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Østergaard M, Lambert RG. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum. 2009;60:93–102.
pubmed: 19116919 doi: 10.1002/art.24132
Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2013;45:730.
pubmed: 23749187 pmcid: 3757343 doi: 10.1038/ng.2667
Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011;12:745.
pubmed: 21946919 doi: 10.1038/nrg3031
Brown MA, Kennedy LG, Macgregor AJ, Darke C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins the role of genes, HLA, and the environment. Arthritis Rheum. 1997;40:1823–8.
pubmed: 9336417 doi: 10.1002/art.1780401015
Ji X, Sun K, Hu Z, Zhang Y, Ma Y, Sun Z, et al. Comparison of clinical manifestations according to HLA-B (27) genotype in ankylosing spondylitis patients: real-world evidence from smart management system for spondyloarthritis. Zhonghua nei ke za zhi. 2018;57:179–84.
pubmed: 29518861
Timms AE, Crane AM, Sims A-M, Cordell HJ, Bradbury LA, Abbott A, et al. The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet. 2004;75:587–95.
pubmed: 15309690 pmcid: 1182046 doi: 10.1086/424695
Rabbani B, Tekin M, Mahdieh N. The promise of whole-exome sequencing in medical genetics. J Hum Genet. 2014;59:5.
pubmed: 24196381 doi: 10.1038/jhg.2013.114
Robinson PC, Leo PJ, Pointon JJ, Harris J, Cremin K, Bradbury LA, et al. Exome-wide study of ankylosing spondylitis demonstrates additional shared genetic background with inflammatory bowel disease. NPJ Genom Med. 2016;1:16008.
pubmed: 29263810 pmcid: 5685324 doi: 10.1038/npjgenmed.2016.8
Moll J, Wright V. New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis. 1973;32:354.
pubmed: 4269429 pmcid: 1006116 doi: 10.1136/ard.32.4.354
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–9.
pubmed: 2440339 doi: 10.1016/0003-2697(87)90021-2
Bava KA, Gromiha MM, Uedaira H, Kitajima K, Sarai A. ProTherm, version 4.0: thermodynamic database for proteins and mutants. Nucleic Acids Res. 2004;32:D120–1.
pubmed: 14681373 pmcid: 308816 doi: 10.1093/nar/gkh082
Homer N, Merriman B, Nelson SF. BFAST: an alignment tool for large scale genome resequencing. PloS one. 2009;4:e7767.
pubmed: 19907642 pmcid: 2770639 doi: 10.1371/journal.pone.0007767
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078–9.
pubmed: 19505943 pmcid: 2723002 doi: 10.1093/bioinformatics/btp352
Leinonen R, Sugawara H, Shumway M. Collaboration INSD The sequence read archive. Nucleic Acids Res. 2010;39:D19–21.
pubmed: 21062823 pmcid: 3013647 doi: 10.1093/nar/gkq1019
Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v. 2.0: the next generation in gene variant databases. Hum Mutat. 2011;32:557–63.
pubmed: 21520333 doi: 10.1002/humu.21438
Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2015;44:D862–8.
pubmed: 26582918 pmcid: 4702865 doi: 10.1093/nar/gkv1222
Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369:1379–90.
pubmed: 17448825 doi: 10.1016/S0140-6736(07)60635-7
O’rielly DD, Uddin M, Rahman P. Ankylosing spondylitis: beyond genome-wide association studies. Curr Opin Rheumatol. 2016;28:337–45.
pubmed: 27224740 doi: 10.1097/BOR.0000000000000297
Smalheiser NR, Costa E, Guidotti A, Impagnatiello F, Auta J, Lacor P, et al. Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells. Proc Natl Acad Sci. 2000;97:1281–6.
pubmed: 10655522 doi: 10.1073/pnas.97.3.1281
D'Arcangelo G, Miao GG, Chen S-C, Scares HD, Morgan JI, Curran T: A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature. 1995;374:719–23.
pubmed: 7715726 doi: 10.1038/374719a0
D’Arcangelo G, Nakajima K, Miyata T, Ogawa M, Mikoshiba K, Curran T. Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody. J Neurosci. 1997;17:23–31.
pubmed: 8987733 pmcid: 6793694 doi: 10.1523/JNEUROSCI.17-01-00023.1997
Ranaivoson FM, von Daake S, Comoletti D. Structural insights into reelin function: present and future. Front Cell Neurosci. 2016;10:137.
pubmed: 27303268 pmcid: 4882317 doi: 10.3389/fncel.2016.00137
Esmaeilzadeh-Gharehdaghi E, Razmara E, Bitaraf A, Mahmoudi M, Garshasbi M. S3440P substitution in C-terminal region of human reelin dramatically impairs secretion of reelin from HEK 293T cells. Cell Mol Biol. 2019;65:12–6.
pubmed: 31472042 doi: 10.14715/cmb/2019.65.6.3
Hong SE, Shugart YY, Huang DT, Al Shahwan S, Grant PE, Hourihane JOB, et al. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet. 2000;26:93.
pubmed: 10973257 doi: 10.1038/79246
Nishibe M, Katsuyama Y, Yamashita T. Developmental abnormality contributes to cortex-dependent motor impairments and higher intracortical current requirement in the reeler homozygous mutants. Brain Struct Funct. 2018;1–13.
Seripa D, Matera MG, Franceschi M, Daniele A, Bizzarro A, Rinaldi M, et al. The RELN locus in Alzheimer’s disease. J Alzheimers Dis. 2008;14:335–44.
pubmed: 18599960 doi: 10.3233/JAD-2008-14308
Lammert DB, Howell BW. RELN mutations in autism spectrum disorder. Front Cell Neurosci. 2016;10:84.
pubmed: 27064498 pmcid: 4814460 doi: 10.3389/fncel.2016.00084
Guidotti A, Grayson DR, Caruncho HJ. Epigenetic RELN dysfunction in schizophrenia and related neuropsychiatric disorders. Front Cell Neurosci. 2016;10:89.
pubmed: 27092053 pmcid: 4820443 doi: 10.3389/fncel.2016.00089
Capriotti E, Fariselli P, Casadio R. I-Mutant2. 0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 2005;33:W306–10.
pubmed: 15980478 pmcid: 1160136 doi: 10.1093/nar/gki375
Arnaud L, Ballif BA, Förster E, Cooper JA. Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. Curr Biol. 2003;13:9–17.
pubmed: 12526739 doi: 10.1016/S0960-9822(02)01397-0
Suetsugu S, Tezuka T, Morimura T, Hattori M, Mikoshiba K, Yamamoto T, et al. Regulation of actin cytoskeleton by mDab1 through N-WASP and ubiquitination of mDab1. Biochem J. 2004;384:1–8.
pubmed: 15361067 pmcid: 1134082 doi: 10.1042/BJ20041103
Du Y, Yang M, Wei W, Huynh H, Herz J, Saghatelian A, et al. Macrophage VLDL receptor promotes PAFAH secretion in mother’s milk and suppresses systemic inflammation in nursing neonates. Nat Commun. 2012;3:1008.
pubmed: 22910354 pmcid: 3520613 doi: 10.1038/ncomms2011
Magnani A, Pattacini L, Boiardi L, Casali B, Salvarani C. Reelin levels are increased in synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2010;28:546–8.
pubmed: 20659411
You S, Cho C-S, Lee I, Hood L, Hwang D, Kim W-U. A systems approach to rheumatoid arthritis. PLoS One 2012;7:e51508.
pubmed: 23240033 pmcid: 3519858 doi: 10.1371/journal.pone.0051508
Inman R, El-Gabalawy H. The immunology of ankylosing spondylitis and rheumatoid arthritis: a tale of similarities and dissimilarities. Clin Exp Rheumatol. 2009;27:S26.
pubmed: 19822042
Greenjohnson J, Zalcman S, Vriend C, Nance D, Greenberg A. Suppressed T cell and macrophage function in the” reeler”(rl/rl) mutant, a murine strain with elevated cerebellar norepinephrine concentration. Brain Behav Immun. 1995;9:47–60.
doi: 10.1006/brbi.1995.1005
Smith JA, Barnes MD, Hong D, DeLay ML, Inman RD, Colbert RA. Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-gamma dysregulation. Arthritis Rheum. 2008;58:1640–9.
pubmed: 18512784 pmcid: 2888278 doi: 10.1002/art.23512
Sabzevary-Ghahfarokhi M, Shohan M, Shirzad H, Rahimian G, Bagheri N, Soltani A, et al. The expression analysis of Fra-1 gene and IL-11 protein in Iranian patients with ulcerative colitis. BMC Immunol. 2018;19:17.
pubmed: 29914371 pmcid: 6006762 doi: 10.1186/s12865-018-0257-9
van den Berg R, Jongbloed EM, de Schepper EIT, Bierma-Zeinstra SMA, Koes BW, Luijsterburg PAJ. The association between pro-inflammatory biomarkers and nonspecific low back pain: a systematic review. Spine J. 2018.
Dougados M, Béhier JM, Jolchine I, Calin A, van der Heijde D, Olivieri I, et al. Efficacy of celecoxib, a cyclooxygenase 2–specific inhibitor, in the treatment of ankylosing spondylitis: A six‐week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum. 2001;44:180–5.
pubmed: 11212158 doi: 10.1002/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K
Carvajal AE, Vázquez-Carretero MD, García-Miranda P, Peral MJ, Calonge ML, Ilundain AA. Reelin expression is up-regulated in mice colon in response to acute colitis and provides resistance against colitis. Biochim Biophys Acta. 2017;1863:462–73.
doi: 10.1016/j.bbadis.2016.11.028
Ding Y, Huang L, Xian X, Yuhanna IS, Wasser CR, Frotscher M, et al. Loss of Reelin protects against atherosclerosis by reducing leukocyte–endothelial cell adhesion and lesion macrophage accumulation. Sci Signal. 2016;9:ra29.
pubmed: 26980442 pmcid: 5053773 doi: 10.1126/scisignal.aad5578
Lories RJ, Luyten FP, De Vlam K. Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther. 2009;11:221.
pubmed: 19439035 pmcid: 2688182 doi: 10.1186/ar2642
Lee GH, D’Arcangelo G. New insights into reelin-mediated signaling pathways. Front Cell Neurosci. 2016;10:122.
pubmed: 27242434 pmcid: 4860420
D’Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran T. Reelin is a ligand for lipoprotein receptors. Neuron. 1999;24:471–9.
pubmed: 10571240 doi: 10.1016/S0896-6273(00)80860-0
Bock HH, Jossin Y, Liu P, Förster E, May P, Goffinet AM, et al. Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J Biol Chem. 2003;278:38772–9.
pubmed: 12882964 doi: 10.1074/jbc.M306416200
Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell. 2005;8:739–50.
pubmed: 15866164 doi: 10.1016/j.devcel.2005.03.016
Zhang J, Zhang X, Zhang L, Zhou F, van Dinther M, ten Dijke P. LRP8 mediates Wnt/β‐catenin signaling and controls osteoblast differentiation. J Bone Min Res. 2012;27:2065–74.
doi: 10.1002/jbmr.1661

Auteurs

Masoud Garshasbi (M)

Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, 14115-111, Iran.

Mahdi Mahmoudi (M)

Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran. mahmoudim@tums.ac.ir.
Inflammation Research Center, Tehran University of Medical Sciences, Tehran, Iran. mahmoudim@tums.ac.ir.

Ehsan Razmara (E)

Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, 14115-111, Iran.

Mahdi Vojdanian (M)

Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Inflammation Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Saeed Aslani (S)

Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Elham Farhadi (E)

Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Inflammation Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Lars Riff Jensen (LR)

Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany.
Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany.

Seyed Masoud Arzaghi (SM)

Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Shiva Poursani (S)

Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Inflammation Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Amirreza Bitaraf (A)

Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.

Milad Eidi (M)

Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, 14115-111, Iran.

Elika Esmaeilzadeh Gharehdaghi (EE)

Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, 14115-111, Iran.

Andreas Walter Kuss (AW)

Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany.

Ahmadreza Jamshidi (A)

Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran. jamshida@tums.ac.ir.
Inflammation Research Center, Tehran University of Medical Sciences, Tehran, Iran. jamshida@tums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH